UNIGE document Scientific Article
previous document  unige:76399  next document
add to browser collection

Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies

Emmert, Maximilian Y
Wolint, Petra
Weber, Benedikt
Brokopp, Chad E
Falk, Volkmar
show hidden authors show all authors [1 - 11]
Published in Biomaterials. 2013, vol. 34, no. 27, p. 6339-6354
Abstract Cardiac stem cell therapy has been proposed as a therapy option to treat the diseased myocardium. However, the low retention rate of transplanted single-cell suspensions remains a major issue of current therapy strategies. Therefore, the concept of scaffold-free cellular self-assembly into three-dimensional microtissues (3D-MTs) prior to transplantation may be beneficial to enhance retention and survival. We compared clinically relevant, human stem cell sources for their ability to generate 3D-MTs with particular regards to formation characteristics, proliferation-activity, viability and extracellular-matrix production. Single-cell suspensions of human bone marrow- and adipose tissue-derived mesenchymal stem cells (hBMMSCs and hATMSCs), Isl1(+) cardiac progenitors derived from human embryonic stem cells (hESC-Isl1(+) cells), and undifferentiated human induced pluripotent cells (hiPSCs) were characterized before to generate 3D-MTs using a hanging-drop culture. Besides the principal feasibility of cell-specific 3D-MT formation, a detailed head-to-head comparison between cell sources was performed using histology, immunocyto- and histo-chemistry as well as flow cytometry. Round-oval shaped and uniform 3D-MTs could be successfully generated from all cell types starting with a loose formation within the first 24 h that fully stabilized after 3 days and resulting in a mean 3D-MT diameter of 194.56 ± 18.01 μm (hBMMSCs), 194.56 ± 16.30 μm (hATMSCs), 159.73 ± 19.20 μm (hESC-Isl1(+) cells) and 120.95 ± 7.97 μm (hiPSCs). While all 3D-MTs showed a homogenous cell distribution, hiPSC-derived 3D-MTs displayed a compact cell formation primarily located at the outer margin. hESC-Isl1(+) and hiPSC-derived 3D-MTs maintained their proliferation-activity which was rather limited in the MSC-based 3D-MTs. All four 3D-MT types revealed a comparable viability in excess of 70% and showed a cell-specific expression profile being comparable to their single-cell counterparts. Extracellular matrix (ECM) production during 3D-MT formation was observed for all cell-specific 3D-MTs, with hiPSC-derived 3D-MTs being the fastest one. Interestingly, ECM distribution was homogenous for hATMSC- and hiPSC-based 3D-MTs, while it appeared to be primarily concentrated within in the center of hESC-Isl1(+) and hBMMSC-based 3D-MTs. The results of this head-to-head comparative study indicated that 3D-MTs can be successfully generated from hESC-derived Isl1(+) cells, hiPSCs and MSC lines upon hanging drop culture. Cell-specific 3D-MTs displayed sufficient viability and instant ECM formation. The concept of 3D-MT in vitro generation prior to cell transplantation may represent a promising delivery format for future strategies to enhance cellular engraftment and survival.
Keywords Cell DifferentiationCell ProliferationCell- and Tissue-Based TherapyCells, CulturedEmbryonic Stem Cells/cytologyHumansInduced Pluripotent Stem Cells/cytologyMesenchymal Stromal Cells/cytologyMyocardium/cytologyTissue Engineering/methods
PMID: 23727259
Full text
Article (Published version) (6.5 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research group Mécanismes de différentiation cellulaire des cellules cardiaques (536)
(ISO format)
EMMERT, Maximilian Y et al. Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies. In: Biomaterials, 2013, vol. 34, n° 27, p. 6339-6354. doi: 10.1016/j.biomaterials.2013.04.034 https://archive-ouverte.unige.ch/unige:76399

422 hits

1 download


Deposited on : 2015-10-23

Export document
Format :
Citation style :